Fluticasone furoate, umeclidinium, vilanterol 100/62.5/25mcg, 200/62.5/25mcg; per inh; dry pwd for oral inhalation. Trelegy Ellipta is supplied as a disposable light grey and beige plastic inhaler ...

The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults ... because the FDA is strict about approving generics for drug-device combinations. Advair generics finally ...

is off-patent and only the FDA’s tough approach to copies of therapies combining an inhaler and a drug is keeping competitors at bay. The new US indication for Trelegy is for the long-term ...

Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $3.3bn in 2024 sales, followed by Relvar/Breo Ellipta and Seretide/Advair GlobalData is the patent company of ...